These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 2645702)
1. Renal allograft biopsy and conversion of cyclosporine to azathioprine. Shen SY; Weir MR; Coughlin TR Transplantation; 1989 Feb; 47(2):223-9. PubMed ID: 2645702 [TBL] [Abstract][Full Text] [Related]
2. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine. Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707 [TBL] [Abstract][Full Text] [Related]
3. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106 [TBL] [Abstract][Full Text] [Related]
4. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years. Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431 [TBL] [Abstract][Full Text] [Related]
5. Results of conversion from cyclosporine to azathioprine in cadaveric renal transplantation. Gonwa TA; Nghiem DD; Schulak JA; Corry RJ Transplantation; 1987 Feb; 43(2):225-8. PubMed ID: 3544380 [TBL] [Abstract][Full Text] [Related]
6. Evidence that addition of azathioprine improves renal function in cyclosporine-treated patients with allograft dysfunction. Pascual J; Marcén R; Orofino L; Quereda C; Mampaso F; Liaño F; Ortuño J Transplantation; 1991 Aug; 52(2):276-9. PubMed ID: 1871800 [TBL] [Abstract][Full Text] [Related]
7. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224 [TBL] [Abstract][Full Text] [Related]
8. Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation. Thistlethwaite JR; Haag BW; Jones KW; Stuart JK; Stuart FP Hum Immunol; 1985 Nov; 14(3):314-23. PubMed ID: 3902749 [TBL] [Abstract][Full Text] [Related]
9. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure. Maddux MS; Veremis SA; Pollak R; Mozes MF Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066 [TBL] [Abstract][Full Text] [Related]
10. Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation. Kupin WL; Venkatachalam KK; Oh HK; Dienst S; Levin NW Transplantation; 1985 Dec; 40(6):601-4. PubMed ID: 3907029 [TBL] [Abstract][Full Text] [Related]
11. Complete replacement of methylprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients. Kupin W; Venkat KK; Oh HK; Dienst S Transplantation; 1988 Jan; 45(1):53-5. PubMed ID: 3276062 [TBL] [Abstract][Full Text] [Related]
12. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers. Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184 [TBL] [Abstract][Full Text] [Related]
13. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
14. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction. Thistlethwaite JR; Woodle ES; Mayes JT; Stuart JK; Heffron TG; Spargo BH; Stuart FP Transplant Proc; 1989 Feb; 21(1 Pt 2):1890-2. PubMed ID: 2652614 [No Abstract] [Full Text] [Related]
15. A prospective randomised comparative study on the influence of cyclosporin and azathioprine on renal allograft survival and function. Henny FC; Kootte AM; Van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC Nephrol Dial Transplant; 1986; 1(1):44-9. PubMed ID: 3110662 [TBL] [Abstract][Full Text] [Related]
16. HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function. Sumrani N; Delaney V; Ding ZK; Butt K; Hong J Am J Kidney Dis; 1990 Nov; 16(5):417-22. PubMed ID: 2239931 [TBL] [Abstract][Full Text] [Related]
17. Improved outcome of renal transplantation with cyclosporine compared with azathioprine--experience in 33 recipients followed for over one year. Yasumura T; Ohmori Y; Aikawa I; Fukuda M; Suzuki S; Nakai I; Matsui S; Oka T Jpn J Surg; 1986 May; 16(3):181-8. PubMed ID: 3525928 [TBL] [Abstract][Full Text] [Related]
18. Effect of early cyclosporine levels on kidney allograft rejection. Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683 [TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Sollinger HW Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033 [TBL] [Abstract][Full Text] [Related]
20. An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone. Wrenshall LE; Matas AJ; Canafax DM; Min DI; Sibley RJ; Dunn DL; Payne WD; Sutherland DE; Najarian JS Transplantation; 1990 Aug; 50(2):233-7. PubMed ID: 2382291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]